Investor Relations

CHF Solutions is an early stage company focused on commercializing the Aquadex FlexFlow® system. Our objective is to improve the quality of life for patients with heart failure and related conditions, such as fluid overload. CHF Solutions is listed on the NASDAQ Capital Market.

Press Releases

Posted on Nov 22, 2017
EDEN PRAIRIE, Minn., Nov. 22, 2017 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ:CHFS) announced today the pricing of an underwritten public offering of Series F convertible preferred stock, together with warrants, for gross proceeds of $18.0 million, prior to deducting underwriting discounts an...

Read More

Posted on Nov 7, 2017
EDEN PRAIRIE, Minn., Nov. 07, 2017 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ:CHFS) announced today that the Heart Failure Reviews released a comprehensive meta-analysis1 evaluating the role of ultrafiltration (UF) in reducing hospital readmissions in acute decompensated heart failure (ADHF) ...

Read More

Posted on Oct 31, 2017
EDEN PRAIRIE, Minn., Oct. 31, 2017 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ:CHFS) announced today its third quarter 2017 results, for the period ending September 30, 2017, which included the following highlights: Revenue for third quarter ended September 30, 2017 increased 21% compared...

Read More

Events & Presentations

Posted on Oct 31, 2017 at 9:00 AM ET
Posted on Sep 26, 2017 at 1:30 PM ET
Posted on Aug 22, 2017 at 3:35 PM CT